Literature DB >> 11264392

Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

S Bhardwaj1, M Holbrook, R E Shope, A D Barrett, S J Watowich.   

Abstract

The molecular determinants responsible for flavivirus host cell binding and tissue tropism are largely unknown, although domain III of the envelope protein has been implicated in these functions. We examined the solution properties and antagonist activity of Langat virus domain III. Our results suggest that domain III adopts a stably folded structure that can mediate binding of tick-borne flaviviruses but not mosquito-borne flaviviruses to their target cells. Three clusters of phylogenetically conserved residues are identified that may be responsible for the vector-specific antagonist activity of domain III.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264392      PMCID: PMC114894          DOI: 10.1128/JVI.75.8.4002-4007.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile.

Authors:  W F Stafford
Journal:  Anal Biochem       Date:  1992-06       Impact factor: 3.365

2.  Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants.

Authors:  H Ni; K D Ryman; H Wang; M F Saeed; R Hull; D Wood; P D Minor; S J Watowich; A D Barrett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Calculation of protein conformation from circular dichroism.

Authors:  J T Yang; C S Wu; H M Martinez
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 4.  Flavivirus vaccines.

Authors:  J R Stephenson
Journal:  Vaccine       Date:  1988-12       Impact factor: 3.641

5.  Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site.

Authors:  C W Mandl; S L Allison; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

Authors:  R S Lanciotti; J T Roehrig; V Deubel; J Smith; M Parker; K Steele; B Crise; K E Volpe; M B Crabtree; J H Scherret; R A Hall; J S MacKenzie; C B Cropp; B Panigrahy; E Ostlund; B Schmitt; M Malkinson; C Banet; J Weissman; N Komar; H M Savage; W Stone; T McNamara; D J Gubler
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

7.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

Review 8.  Towards a new generation of flavivirus vaccines.

Authors:  K Venugopal; E A Gould
Journal:  Vaccine       Date:  1994-08       Impact factor: 3.641

9.  Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus.

Authors:  C W Naeve; V S Hinshaw; R G Webster
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

Review 10.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more
  60 in total

1.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Authors:  David W C Beasley; Alan D T Barrett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody.

Authors:  Bimmi Shrestha; S Kyle Austin; Kimberly A Dowd; Abhishek N Prasad; Soonjeon Youn; Theodore C Pierson; Daved H Fremont; Gregory D Ebel; Michael S Diamond
Journal:  Virology       Date:  2012-03-09       Impact factor: 3.616

4.  Visualization of membrane protein domains by cryo-electron microscopy of dengue virus.

Authors:  Wei Zhang; Paul R Chipman; Jeroen Corver; Peter R Johnson; Ying Zhang; Suchetana Mukhopadhyay; Timothy S Baker; James H Strauss; Michael G Rossmann; Richard J Kuhn
Journal:  Nat Struct Biol       Date:  2003-10-05

5.  Structures of immature flavivirus particles.

Authors:  Ying Zhang; Jeroen Corver; Paul R Chipman; Wei Zhang; Sergei V Pletnev; Dagmar Sedlak; Timothy S Baker; James H Strauss; Richard J Kuhn; Michael G Rossmann
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

6.  Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.

Authors:  Michael R Holbrook; Robert E Shope; Alan D T Barrett
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  Conformational changes of the flavivirus E glycoprotein.

Authors:  Ying Zhang; Wei Zhang; Steven Ogata; David Clements; James H Strauss; Timothy S Baker; Richard J Kuhn; Michael G Rossmann
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

8.  Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein.

Authors:  John T Roehrig; Katharine E Volpe; Jennifer Squires; Ann R Hunt; Brent S Davis; Gwong-Jen J Chang
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

10.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.